(Q41644232)

25433014

6 October 2017

title

Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys (English)

1 reference

6 October 2017

Shihui Sun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Guangyu Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Chenfeng Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wei Fan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xiaojun Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Lin Zeng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yan Guo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zhihua Kou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Hong Yu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Junfeng Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yan Li

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Conny Schneider

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Maria Habel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Niels C Riedemann

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yusen Zhou

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Lanying Du

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Shibo Jiang

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

27 November 2014

1 reference

25433014

Clinical Infectious Diseases

6 October 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

586-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

Avian influenza A (H5N1) infection in humans

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Complement in immune and inflammatory disorders: pathophysiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

The effect of C1 inhibitor on myocardial ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

The role of complement in the development of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

The role of the anaphylatoxins in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Inhibiting the C5-C5a receptor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Attenuation of cross-talk between the complement and coagulation cascades by C5a blockade improves early outcomes after intraportal islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

C5 deficiency and C5a or C5aR blockade protects against cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

C1-inhibitor: more than a serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - perfect example for a fast track from bench to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Complement in immune and inflammatory disorders: therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Clinical findings in 111 cases of influenza A (H7N9) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Biological features of novel avian influenza A (H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU887

Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation

21 January 2018

1 reference

12 December 2020

Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis

1 reference

12 December 2020

Drug evaluation: the C5a receptor antagonist PMX-53.

1 reference

12 December 2020

Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself

1 reference

12 December 2020

Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza

1 reference

12 December 2020

Novel complementary peptides to target molecules.

1 reference

12 December 2020

C3c intrathecal synthesis evaluation in patients with multiple sclerosis

1 reference

12 December 2020

Steroid-induced osteonecrosis: the number of lesions is related to the dosage

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIU887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25433014%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

25433014

1 reference